| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial MP Manns, JG McHutchison, SC Gordon, VK Rustgi, M Shiffman, ... The lancet 358 (9286), 958-965, 2001 | 8188 | 2001 |
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis F Alvarez, PA Berg, FB Bianchi, L Bianchi, AK Burroughs, EL Cancado, ... Journal of hepatology 31 (5), 929-938, 1999 | 3482 | 1999 |
| Classification of chronic hepatitis: diagnosis, grading and staging VJ Desmet, M Gerber, JH Hoofnagle, M Manns, PJ Scheuer Hepatology 19 (6), 1513-1520, 1994 | 3306 | 1994 |
| Boceprevir for untreated chronic HCV genotype 1 infection F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ... New England Journal of Medicine 364 (13), 1195-1206, 2011 | 3272 | 2011 |
| Diagnosis and management of autoimmune hepatitis MP Manns, AJ Czaja, JD Gorham, EL Krawitt, G Mieli‐Vergani, D Vergani, ... Hepatology 51 (6), 2193-2213, 2010 | 1867 | 2010 |
| Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis AJ van der Meer, BJ Veldt, JJ Feld, H Wedemeyer, JF Dufour, F Lammert, ... Jama 308 (24), 2584-2593, 2012 | 1771 | 2012 |
| Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B P Marcellin, EJ Heathcote, M Buti, E Gane, RA de Man, Z Krastev, ... New England Journal of Medicine 359 (23), 2442-2455, 2008 | 1434 | 2008 |
| Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C T Poynard, J McHutchison, M Manns, C Trepo, K Lindsay, Z Goodman, ... Gastroenterology 122 (5), 1303-1313, 2002 | 1432 | 2002 |
| Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C JG McHutchison, M Manns, K Patel, T Poynard, KL Lindsay, C Trepo, ... Gastroenterology 123 (4), 1061-1069, 2002 | 1306 | 2002 |
| Treatment of acute hepatitis C with interferon alfa-2b E Jaeckel, M Cornberg, H Wedemeyer, T Santantonio, J Mayer, M Zankel, ... New England Journal of Medicine 345 (20), 1452-1457, 2001 | 1136 | 2001 |
| Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C GL Davis, JB Wong, JG McHutchison, MP Manns, J Harvey, J Albrecht Hepatology 38 (3), 645-652, 2003 | 1121 | 2003 |
| Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C A Takaki, M Wiese, G Maertens, E Depla, U Seifert, A Liebetrau, JL Miller, ... Nature medicine 6 (5), 578-582, 2000 | 934 | 2000 |
| Telaprevir for previously treated chronic HCV infection JG McHutchison, MP Manns, AJ Muir, NA Terrault, IM Jacobson, ... New England Journal of Medicine 362 (14), 1292-1303, 2010 | 933 | 2010 |
| 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B YF Liaw, E Gane, N Leung, S Zeuzem, Y Wang, CL Lai, EJ Heathcote, ... Gastroenterology 136 (2), 486-495, 2009 | 914 | 2009 |
| Treating viral hepatitis C: efficacy, side effects, and complications MP Manns, H Wedemeyer, M Cornberg Gut 55 (9), 1350-1359, 2006 | 904 | 2006 |
| A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+ CD25+ Foxp3+ T cells B Hoechst, LA Ormandy, M Ballmaier, F Lehner, C Krüger, MP Manns, ... Gastroenterology 135 (1), 234-243, 2008 | 897 | 2008 |
| Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma LA Ormandy, T Hillemann, H Wedemeyer, MP Manns, TF Greten, ... Cancer research 65 (6), 2457-2464, 2005 | 870 | 2005 |
| Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis BJ Veldt, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ... Annals of internal medicine 147 (10), 677-684, 2007 | 846 | 2007 |
| Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C T Poynard, V Ratziu, J McHutchison, M Manns, Z Goodman, S Zeuzem, ... Hepatology 38 (1), 75-85, 2003 | 762 | 2003 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 760 | 2019 |
